PubRank

Numa Cellini

Author PubWeight™ 46.79‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. Ann Surg Oncol 2009 1.70
2 Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). Radiother Oncol 2009 1.55
3 The prognostic effect of clinical staging in pancreatic adenocarcinoma. Ann Surg Oncol 2005 1.50
4 Chemoradiation and brachytherapy in biliary tract carcinoma: long-term results. Int J Radiat Oncol Biol Phys 2005 1.09
5 Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. Radiother Oncol 2002 1.09
6 Stereotactic radiotherapy in recurrent gynecological cancer: a case series. Oncol Rep 2009 1.06
7 Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. Radiother Oncol 2008 1.01
8 Phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with inoperable non-small-cell lung cancer. J Clin Oncol 2002 0.97
9 Squamous cell carcinoma antigen in follow-up of cervical cancer treated with radiotherapy: evaluation of cost-effectiveness. Int J Radiat Oncol Biol Phys 2007 0.95
10 Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? J Appl Clin Med Phys 2011 0.94
11 The multidisciplinary rectal cancer treatment: main convergences, controversial aspects and investigational areas which support the need for an European Consensus. Radiother Oncol 2005 0.92
12 Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy. Int J Radiat Oncol Biol Phys 2012 0.92
13 Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study. Acta Oncol 2011 0.91
14 A phase I dose-escalation study (ISIDE-BT-1) of accelerated IMRT with temozolomide in patients with glioblastoma. Int J Radiat Oncol Biol Phys 2009 0.91
15 Application of a practical method for the isocenter point in vivo dosimetry by a transit signal. Phys Med Biol 2007 0.91
16 Combined-modality therapy in locally advanced primary rectal cancer. Dis Colon Rectum 2003 0.89
17 Pain relief with short-term irradiation in locally advanced carcinoma of the pancreas. J Palliat Care 2003 0.88
18 Complexity index (COMIX) and not type of treatment predicts undetected errors in radiotherapy planning and delivery. Radiother Oncol 2008 0.88
19 Chemoradiation with raltitrexed (Tomudex) in preoperative treatment of stage II-III resectable rectal cancer: a phase II study. Int J Radiat Oncol Biol Phys 2004 0.87
20 Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy. Int J Radiat Oncol Biol Phys 2011 0.87
21 Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II-III resectable rectal cancer: Phase I and II studies. Int J Radiat Oncol Biol Phys 2004 0.86
22 Daily on-line set-up correction in 3D-conformal radiotherapy: is it feasible? Tumori 2012 0.85
23 Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). Gynecol Oncol 2010 0.84
24 Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. Int J Radiat Oncol Biol Phys 2008 0.84
25 Long-term results after neoadjuvant radiochemotherapy for locally advanced resectable extraperitoneal rectal cancer. Dis Colon Rectum 2006 0.84
26 Radioprotective effect of moderate wine consumption in patients with breast carcinoma. Int J Radiat Oncol Biol Phys 2009 0.84
27 Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer. Radiat Oncol 2012 0.83
28 Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: a dose-escalation trial. Urol Oncol 2011 0.83
29 Neoadjuvant accelerated concomitant boost radiotherapy and multidrug chemotherapy in locally advanced rectal cancer: a dose-escalation study. Am J Clin Oncol 2012 0.82
30 External beam radiotherapy plus 24-hour continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long-term results of a phase II study. Int J Radiat Oncol Biol Phys 2009 0.82
31 Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity. Am J Clin Oncol 2012 0.81
32 Feasibility study of moderately accelerated intensity-modulated radiotherapy plus concurrent weekly cisplatin after induction chemotherapy in locally advanced head-and neck cancer. Int J Radiat Oncol Biol Phys 2010 0.81
33 Radiotherapy-related fatigue: incidence and predictive factors. Rays 2005 0.81
34 5-fluorouracil-based chemoradiation in unresectable pancreatic carcinoma: Phase I-II dose-escalation study. Int J Radiat Oncol Biol Phys 2004 0.80
35 Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection. Int J Radiat Oncol Biol Phys 2007 0.80
36 Early radiation-induced mucosal changes evaluated by proctoscopy: predictive role of dosimetric parameters. Radiother Oncol 2012 0.80
37 Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. Strahlenther Onkol 2010 0.80
38 Impact of dose and volume on radiation-induced mucositis. Rays 2005 0.79
39 Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series. Cancer Invest 2012 0.79
40 A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases. Int J Radiat Oncol Biol Phys 2012 0.79
41 Short-course accelerated radiotherapy in palliative treatment of advanced pelvic malignancies: a phase I study. Int J Radiat Oncol Biol Phys 2012 0.79
42 Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial. Oncol Lett 2013 0.79
43 Preoperative chemoradiation and intra-operative radiotherapy for pancreatic carcinoma. Tumori 2007 0.78
44 Videoconferencing to enhance the integration between clinical medicine and teaching: a feasibility study. Tumori 2009 0.78
45 Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report. Int J Biol Markers 2010 0.78
46 An application of visible human database in radiotherapy: tutorial for image guided external radiotherapy (TIGER). Radiother Oncol 2004 0.77
47 In vivo dosimetry by an aSi-based EPID. Med Phys 2006 0.77
48 Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1). Gynecol Oncol 2012 0.77
49 Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison. Med Dosim 2010 0.77
50 Lymphatic drainage and CTV in pancreatic carcinoma. Rays 2004 0.77
51 Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II study. J Neurooncol 2009 0.76
52 Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). Am J Clin Oncol 2010 0.76
53 Neoplastic mesorectal microfoci (MMF) following neoadjuvant chemoradiotherapy: clinical and prognostic implications. Ann Surg Oncol 2007 0.76
54 Mesenteric vein thrombosis after surgery and radiotherapy for pancreatic carcinoma. A case report. Tumori 2004 0.75
55 Chemoradiation of unresectable pancreatic carcinoma: impact of pretreatment hemoglobin level on patterns of failure. Strahlenther Onkol 2003 0.75
56 Postoperative intensity-modulated radiotherapy in low-risk endometrial cancers: final results of a Phase I study. Int J Radiat Oncol Biol Phys 2009 0.75
57 Concomitant radiochemotherapy plus surgery in locally advanced cervical cancer: update of clinical outcome and cyclooxygenase-2 as predictor of treatment susceptibility. Oncology 2004 0.75
58 Complete response after chemoradiation in ampullary carcinoma: a case report. Tumori 2003 0.75
59 Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. Acta Oncol 2010 0.75
60 Neoplastic mesorectal microfoci (MMF) following neoadjuvant chemoradiotherapy: clinical and prognostic implications. Ann Surg Oncol 2006 0.75
61 Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. Tumori 2010 0.75
62 Virtual simulation: fifteen years later. Rays 2004 0.75
63 Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases. Am J Clin Oncol 2015 0.75
64 Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center. Clin J Pain 2013 0.75
65 Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer. Radiol Med 2013 0.75
66 Radiation therapy of breast cancer. Reasoned approach to a clinical case. Rays 2004 0.75
67 3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1). Gynecol Oncol 2010 0.75